Allopurinol/hydroxycarbamideLack of efficacy : case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2037卷 / 1期

关键词：

D O I：

10.1007/s40278-024-71720-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：27 / 27

相关论文

共 50 条

[31] HydroxycarbamideLack of efficacy
Reactions Weekly, 2024, 2009 (1) : 289 - 289
[32] Allopurinol/methylprednisoloneDrug eruption and lack of efficacy: case report
Reactions Weekly, 2021, 1862 (1) : 28 - 28
[33] Anticoagulants/hydroxycarbamideLack of efficacy
Reactions Weekly, 2024, 2003 (1) : 82 - 82
[34] Allopurinol/methylprednisolone/prednisoneDRESS syndrome and lack of efficacy: case report
Reactions Weekly, 2023, 1959 (1) : 46 - 46
[35] Allopurinol/venetoclaxTumour lysis syndrome and lack of efficacy: case report
Reactions Weekly, 2022, 1924 (1) : 34 - 34
[36] Allopurinol/venetoclaxTumour lysis syndrome and lack of efficacy: case report
Reactions Weekly, 2025, 2054 (1) : 29 - 29
[37] Allopurinol/dexamethasoneCholestatic liver injury and lack of efficacy : case report
Reactions Weekly, 2021, 1885 (1) : 41 - 41
[38] Alemtuzumab/Allopurinol/CyclophosphamideVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2025, 2055 (1) : 21 - 21
[39] Antineoplastics/allopurinol/rasburicaseTumour lysis syndrome and lack of efficacy: case report
Reactions Weekly, 2022, 1929 (1) : 87 - 87
[40] Anthracyclines/cytarabine/hydroxycarbamideLack of efficacy
Reactions Weekly, 2024, 1999 (1) : 44 - 44

← 1 2 3 4 5 →